World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
56
Citations
13362
World Ranking
3679
National Ranking
1445

Overview

Veronica Miller is affiliated with the University of California, Berkeley in the United States. Their research primarily focuses on medicine, with significant contributions in epidemiology, infectious diseases, hepatology, virology, and endocrinology, diabetes, and metabolism.

Their main topics of research include liver disease diagnosis and treatment, hepatitis C virus research, HIV/AIDS research and interventions, hepatitis B virus studies, HIV research and treatment, diet, metabolism, and disease, and HIV/AIDS drug development and treatment.

Veronica Miller has published extensively, with recent papers highlighting various aspects of liver diseases, viral infections, and therapies. Notable recent publications include:

  • "Advancing the global public health agenda for NAFLD: a consensus statement" (2021) in Nature Reviews Gastroenterology & Hepatology
  • "A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook" (2022) in Nature Reviews Gastroenterology & Hepatology
  • "NAFLD - sounding the alarm on a silent epidemic" (2020) in Nature Reviews Gastroenterology & Hepatology
  • "Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial" (2020) in The Lancet
  • "Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis" (2020) in Clinical Gastroenterology and Hepatology

Frequently, Miller collaborates with other researchers. Their prominent coauthors include Gabriel Westman, Arun J. Sanyal, Sven Francque, Jörn M. Schattenberg, and Sarah Fidler.

Miller's work appears regularly in journals such as the Journal of Hepatology, Nature Reviews Gastroenterology & Hepatology, Clinical Infectious Diseases, Journal of Virus Eradication, and Hepatology.

The research topics and publication venues reflect a strong focus on liver diseases and viral infections, particularly those affecting public health at large. The combination of epidemiological approaches and clinical studies marks Miller's contributions to advancing understanding and treatment options in infectious and metabolic diseases.

Best Publications

  • Changing patterns of mortality across Europe in patients infected with HIV-1.

    A Mocroft;S Vella;TL Benfield;A Chiesi

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

    Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

    Kurt Hertogs;Marie-Pierre de Béthune;Veronica Miller;Tania Ivens

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

    Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  • HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Andrew N. Phillips;Schlomo Staszewski;Rainer Weber;Ole Kirk

  • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

    Ole Kirk;Court Pedersen;Alessandro Cozzi-Lepri;Francisco Antunes

  • Hepatitis C virus drug resistance–associated substitutions: State of the art summary

    Erik Lontok;Patrick Harrington;Anita Howe;Tara Kieffer

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

    K. Hertogs;S. Bloor;S. D. Kemp;C. van den Eynde

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

    Roy F. Chemaly;Sunwen Chou;Hermann Einsele;Paul Griffiths

  • Protein binding in antiretroviral therapies.

    Marta Boffito;David J. Back;Terrence F. Blaschke;Malcolm Rowland

  • A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.

    B. A. Larder;S. Bloor;S. D. Kemp;Kurt Hertogs

  • HIV-1 Viral Load Assays for Resource-Limited Settings

    Susan A Fiscus;Ben Cheng;Suzanne M Crowe;Lisa Demeter

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Boris Julg;Boris Julg;Lynda Dee;Jintanat Ananworanich;Dan H Barouch;Dan H Barouch

  • Updated European recommendations for the clinical use of HIV drug resistance testing

    A. M. Vandamme;A. Sönnerborg;M. Ait-Khaled;J. Albert

  • HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy.

    Veronica Miller;Mounir Ait-Khaled;Chris Stone;Philip Griffin

Frequent Co-Authors

Schlomo Staszewski
Schlomo Staszewski Goethe University Frankfurt
Andrew N. Phillips
Andrew N. Phillips University College London
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Kurt Hertogs
Kurt Hertogs AZ Monica
Caroline Sabin
Caroline Sabin University College London
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Holger F. Rabenau
Holger F. Rabenau Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, many of which can be further supported by related online degrees. For example, those interested in medical fields might consider exploring what medical degrees can I get online, offering flexible study options to complement microbiology knowledge.

Public health is another relevant field, with many students opting for an advanced degree to broaden their impact. Popular choices include affordable and accessible programs like the online public health masters programs easy to get into, which are designed to accommodate diverse schedules and backgrounds.

For those aiming to work closely with children and families, the role of a child life specialist combines healthcare and psychology. Understanding salary expectations and career requirements is crucial, and resources such as child specialist salary provide valuable insights.

Importantly, online degree options are increasingly inclusive, offering opportunities for students from various backgrounds. For those facing challenges such as past convictions, exploring college degrees for felons helps identify supportive programs that facilitate career advancement in scientific fields.

Best Scientists Citing Veronica Miller

Trending Scientists

Recently Published Articles